$SNPS

Synopsys Falls as Strong Results Fail to Clear a High Bar

Synopsys (SNPS) shares fell 5.9% after reporting Q3 revenue of $2.48B and EPS of $3.91, both above guidance. The company raised full-year targets to $9.715B revenue and $15.07 EPS, but investors reacted negatively due to modest outlook increases, restructuring costs, and acquisition-related expenses. Insider sales and mixed hedge fund activity were also noted.

Original reporting
Published Sep 4, 2026, 2:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 3:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Synopsys Falls as Strong Results Fail to Clear a High Bar — source image
Decision brief

The 30-second read

$SNPSBearishMed
01

Why it matters

The earnings release introduced new guidance and highlighted restructuring costs, directly influencing the stock price.

02

Market read

Earnings-driven price move with fresh guidance and cost details; relevant for traders in tech and semiconductor sectors.

03

What to watch

Potential upside from Ansys integration synergies and long‑term AI‑driven design demand not fully priced in.

Relevance 8/10Novelty 8/10Timing: today

Background

Synopsys' Q3 results were released after a period of high expectations for AI‑driven design tools.

Company-level read

Ticker impact

$SNPSBearishHigh confidence
Context

Synopsys reported Q3 revenue of $2.48B and non‑GAAP EPS $3.91, raised FY guidance, and disclosed $236.3M restructuring charges, prompting a 5.9% drop.

Expected impact

Short‑term downside pressure; potential rebound if guidance is clarified.

Evidence & confidence

The numbers are fresh from the filing and directly moved the stock, indicating material new information.

Market effects

Design‑automation sector may see broader scrutiny of guidance expectations after Synopsys' modest outlook.

U.S. tech equities could face short‑term pressure as investors reassess earnings forecasts.

Limited; impact confined to semiconductor and EDA market participants.

Counterpoint

The stock may be oversold; the strong revenue base and ongoing demand could support a bounce.

Key entities

  • Synopsys

    EDA software provider (ticker SNPS).

Related articles

$AMZNMedAI 8/10

Amazon and Synopsys seal $1bn technology partnership

Amazon and Synopsys have signed a $1 billion deal to accelerate Amazon's custom silicon innovation and advance AI products and cloud infrastructure. The multi-year agreement builds on 15 years of collaboration, with Synopsys providing application-optimized silicon IP. Amazon's Peter DeSantis highlighted the impact of custom silicon on AWS, while Synopsys' Sassine Ghazi emphasized the partnership's role in shaping AI-native engineering.

$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.

$SNPSMed

Morgan Stanley Raises Synopsys (SNPS) Price Target Amid AI Tailw

Morgan Stanley raised Synopsys' (SNPS) price target to $574 from $550, citing AI growth potential. SNPS shares dipped 0.8% premarket. GF Value™ estimates intrinsic value at $661.95, 32.8% above current price. SNPS has a GF Score™ of 93/100, reflecting strong growth and profitability. The stock's P/E ratio is 78.61x, below its 5-year median of 59.07x.